ADRs are prevalent in Chinese paediatric TB patients, predominantly haematological or gastrointestinal, transient during the intensive phase. Severe disease and HRZ(E) + second-line regimens confer elevated risk, necessitating targeted surveillance and optimized paediatric therapies balancing efficacy and safety.
Zhou et al. (Wed,) studied this question.